Literature DB >> 11054393

Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis.

K Cope1, T Risby, A M Diehl.   

Abstract

BACKGROUND & AIMS: Similarities in the hepatic responses to obesity and ethanol exposure suggest that these conditions evoke common pathogenic mechanisms. Thus, it is possible that ethanol exposure is increased in obesity. Given that intestinal bacteria can produce ethanol, the aim of this study was to determine if the intestinal production of ethanol is increased in obesity.
METHODS: Breath was collected from genetically obese, ob/ob male C57BL/6 mice and lean male littermates at different ages (14, 20, and 24 weeks) and times of the day (9 AM, 3 PM, and 9 PM). Obese mice (24 weeks old) were then treated with neomycin (1 mg/mL) for 5 days, and sampling was repeated.
RESULTS: Breath collected in the morning from 24-week-old obese mice had a higher ethanol content than breath from their lean littermates (271 vs. 78 pmol/mL CO(2); P < 0.0001). Subsequent studies in 14- and 20-week-old mice showed that exhaled ethanol increased with age in obese (from 26 to 107 pmol/mL CO(2); P < 0. 002) but not lean (29 and 12 pmol/mL CO(2)) mice and was greater in older obese mice than in older lean mice (P < 0.0006). Obese mice showed a diurnal increase in breath ethanol in the morning that decreased through the afternoon and evening (107 to 33 to 13 pmol/mL CO(2)). Neomycin treatment decreased morning breath ethanol levels by 50% (from 220 to 110 pmol/mL CO(2); P < 0.0003).
CONCLUSIONS: Even in the absence of ethanol ingestion, ethanol can be detected in exhaled breath. In obesity, an age-related increase in breath ethanol content reflects increased production of ethanol by the intestinal microflora. Hence, intestinal production of ethanol may contribute to the genesis of obesity-related fatty liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054393     DOI: 10.1053/gast.2000.19267

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  100 in total

1.  Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients.

Authors:  Ana María Madrid; Jaime Poniachik; Rodrigo Quera; Carlos Defilippi
Journal:  Dig Dis Sci       Date:  2010-05-01       Impact factor: 3.199

2.  Improved predictive models for plasma glucose estimation from multi-linear regression analysis of exhaled volatile organic compounds.

Authors:  Jane Lee; Jerry Ngo; Don Blake; Simone Meinardi; Andria M Pontello; Robert Newcomb; Pietro R Galassetti
Journal:  J Appl Physiol (1985)       Date:  2009-05-07

3.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

4.  Increased intestinal ethanol following consumption of fructooligosaccharides in rats.

Authors:  Masahiro Yamaguchi; Yongshou Yang; Misaki Ando; Thanutchaporn Kumrungsee; Norihisa Kato; Yukako Okazaki
Journal:  Biomed Rep       Date:  2018-09-14

Review 5.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Authors:  Irina A Kirpich; Luis S Marsano; Craig J McClain
Journal:  Clin Biochem       Date:  2015-07-04       Impact factor: 3.281

Review 6.  Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions.

Authors:  Edmund B Chen; Cori Cason; Jack A Gilbert; Karen J Ho
Journal:  J Gastrointest Surg       Date:  2018-04-05       Impact factor: 3.452

7.  Clinical utility of breath ammonia for evaluation of ammonia physiology in healthy and cirrhotic adults.

Authors:  Lisa A Spacek; Matthew Mudalel; Frank Tittel; Terence H Risby; Steven F Solga
Journal:  J Breath Res       Date:  2015-12-14       Impact factor: 3.262

Review 8.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

Review 9.  Hepatic steatosis and type 2 diabetes mellitus.

Authors:  Jeanne M Clark; Anna Mae Diehl
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 10.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.